Why Data-Driven Clinical Pathways Matter Patrick Rogers Chief Marketing Officer, Ayasdi Joshua Lewis Director of UI/UX Engineering, Ayasdi Dr. Seth Barbanell VP of Clinical Performance Acceleration, Mercy Higher spending doesn’t always mean better outcomes… 30% of all healthcare costs are unwarranted ... but do we know which 30%? Company Confidential & Proprietary 2 Challenges with Reducing Variation ? Identifying causes •  Which paths have the highest variation? •  What factors cause the variation? Company Confidential & Proprietary Defining optimal pathways •  What pathways lead to the best outcomes? Adopting best practices •  Will my physicians use these new best practices? 3 Mercy Hospital Profile •  Mercy is the 5th largest Catholic health care system in the U.S. •  33 hospitals, nearly 700 clinic & outpatient facilities, 40,000 co-workers and more than 2,000 Mercy Clinic physicians •  Named one of the “Most Wired” and technologically advanced hospital systems by American Hospital Association. Company Confidential & Proprietary Challenges with Existing Process Physician Inputs Pathway Lead, Population Research Journals, texts, guidelines, protocols, experience Create Preliminary Pathway Evaluation Committee Update Pathway Final Pathway Multiple Iterations Before Consensus Long development cycle :: “Bloated” pathways due to consensus :: Possibly subjective :: Slow adoption Company Confidential & Proprietary Improved Pathway Development EMR & Financial Data Pathway Modeling in Ayasdi Care Pathway created Evaluation Committee Final Optimized Pathway Short development cycle (1 month) :: Data-driven Output :: Fast adoption :: Continuous Improvement Company Confidential & Proprietary Mercy’s Ah-ha Moment! •  Focused on perioperative pathways - knee replacement surgery •  Group of MDs had patients consistently with lower hospital stay and lower costs •  Determined one factor was due to a specific analgesic that was not widely used Company Confidential & Proprietary 7 Together With AYASDI Mercy Expects Company Confidential & Proprietary •  Improved care quality by reducing clinical variation •  Deploy clinical pathways 2x faster •  Increased physician adoption by 20% •  Incremental $100M savings over next 3 years 8 Making Complex Data Useful Billing EHR Data explosion: •  Abundance of data in EHR, claims, pharmacies etc. Company Confidential & Proprietary 9 Making Complex Data Useful Billing EHR Data explosion: •  Abundance of data in EHR, claims, pharmacies etc. Company Confidential & Proprietary Ayasdi Care: •  Data-driven •  Uncovers hidden insights within your data 10 Making Complex Data Useful Billing EHR Data explosion: •  Abundance of data in EHR, claims, pharmacies etc. Company Confidential & Proprietary Ayasdi Care: •  Data-driven •  Uncovers hidden insights within your data Operationalization: •  Delivers clinical insight to provide better patient outcomes 11 Optimize Pathway Development Ayasdi Care •  Mathematically sequences and aggregates procedures •  Determines optimal pathway by your desired outcomes •  Models outcomes based on changes to treatment Company Confidential & Proprietary 12 Drive Pathway Adoption Ayasdi Care •  Improves adoption with datadriven pathways •  Allows personalization down to specific comorbidities •  Decreases time to deploy new best practices Company Confidential & Proprietary 13 Implementing Ayasdi Care Medical & financial data Format and transform data Company Confidential & Proprietary Ayasdi unique topological data analysis Clinical pathway generation Adapted into EMR systems Together With AYASDI •  Ayasdi Care for •  Clinical Pathways •  can help you •  Company Confidential & Proprietary Standardize care practices Reduce process inefficiencies Improve patient outcomes Control hospital costs 15 Ayasdi Care Demonstration 16 Ayasdi Care Tackles other Use Cases CLINICAL PATHWAY DEVELOPMENT DENIALS REDUCTION POPULATION HEALTH & RISK MANAGEMENT COMPARATIVE EFFECTIVENESS OPERATIONAL PRECISION PATHWAYS MEDICINE Care Management Company Confidential & Proprietary Research Operations & Finance 17 Getting Started Discovery Assessment Business Case Validate Email: [email protected] Company Confidential & Proprietary 18 Thank You – Questions?